Skip to main content

Latest RET News

Find here some of the latest news and resources about RET cancer.

Filter

together separately live stream

3/13/24 Live Virtual Meetup About IASLC Targeted Therapies

#TogetherSeparately: live virtual meetup to summarize data presented on February’s IASLC Targeted Therapies Meeting. March 13 at 3PM…
March 11, 2024
harmonic never smoker lung cancer trial

The Harmonic™ Clinical Trial for Never Smokers

New clinical trial for never smokers: The Harmonic™ clinical trial The Harmonic™ clinical trial is…
March 9, 2024
oncogene testing RET lung cancer

Looking Ahead: The Future of Diagnostic Testing for Patients

By: Anthony Sireci, M.D., senior vice president, clinical biomarkers and diagnostics development, Loxo@Lilly Over the…
January 7, 2024
ret cancer research 2023

2023 RET Cancer Research Update

2023 Happy Lungs Project RET research update On Friday December 8th, the Happy Lungs Project…
December 18, 2023
RET lung cancer study 2023

Exciting Preclinical Results About Vepafestinib

New published study with exciting preclinical results about the second generation RET inhibitor vepafestinib (TAS0953/HM06).  Vepafestinib showed selectivity…
October 10, 2023
lung cancer research

New clinical trial testing amivantamab

New clinical trial testing amivantamab for patients who progressed on RET therapies:  A Phase 1…
October 8, 2023
on and off target ret resistance

Two research studies funded by HLP were presented at 2023 ASCO annual meeting

Last week was the 2023 American Society of Clinical Oncology (ASCO) conference in Chicago. The…
June 19, 2023

Ellipses Pharma presents ‘encouraging’ data on selective RET inhibitor EP0031, ASCO 2023 annual conference

Data of the Phase 1 Study of KL590586 (EP0031/A400), presented at ASCO, reported preliminary efficacy…
June 19, 2023

DAVA’s 2nd Hawaii Global Summit on Thoracic Malignancies

The DAVA’s 2nd Hawaii Global Summit on Thoracic Malignancies is a five-day meeting comprising seven…
June 19, 2023
2022 ret cancer research update happy lungs project

Virtual Event: 2022 RET Cancer Research Update (Watch Video)

The Happy Lungs Project hosted a 2022 Research Update, featuring presentations about advances for RET-positive…
December 13, 2022
lung cancer study

Participants Needed: Epidemiology of Young Lung Cancer Study

Epidemiology of Young Lung Cancer is a clinical study for patients who were diagnosed with…
November 29, 2022
irene guijarro Munoz

Dr. Irene Guijarro Munoz Named Our Science Liaison & Research Manager

Dr. Irene Guijarro Munoz has been named the Science Liaison and Research Manager for the…
September 27, 2022
2022 RET Summit lung cancer

Press Release: Partnering on Innovative Lung Cancer Research

The Happy Lungs Project is pleased to share research that we are funding in collaboration…
May 31, 2022
RET positive lung cancer support

Donors Pledge $2 Million Dollars to Happy Lungs Project in Matching Grant to Fight Lung Cancer

The Happy Lungs Project, Inc., a 501c3 non-profit, was awarded a $2 million matching grant…
May 30, 2022
The Happy Lungs Project RET positive mission

Press Release: Four Major US Cancer Centers Advance RET+ Lung Cancer Research

New Research Collaboration Set To Attack RET Driven Non-Small Cell Lung Cancer April 6, 2022…
April 6, 2022
happy lungs project logo
We are a 501(c)(3) non-profit, patient-driven community. Our mission is to support researchers and clinicians in their work towards finding a cure for RET-Positive Non-Small Cell Lung Cancer, while educating and empowering patients in their own healing journey.

Email: info@happylungsproject.org

Phone: 512-337-9352

Address: 3209 Sunny Ln. Austin, TX 78731

ABOUT
RESOURCES
GET INVOLVED
RESEARCH

© 2024 Happy Lungs Project | Privacy Policy | Terms of Service | Designed by Reinhardt Designs